TETRACYCLIC BROMODOMAIN INHIBITORS

The present invention provides for compounds of formula (I)wherein R, R, R, Y, Y, Y, A, A, A, and Ahave any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory disease...

Full description

Saved in:
Bibliographic Details
Main Authors DAI, Yujia, WANG, Le, SHEPPARD, George S, MANTEI, Robert A, PRATT, John, HOLMS, James H, DIETRICH, Justin D, LIU, Dachun, MARJANOVIC, Jasmina, HASVOLD, Lisa A, BOGDAN, Andrew, FIDANZE, Steven D, MCDANIEL, Keith F
Format Patent
LanguageEnglish
French
German
Published 18.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention provides for compounds of formula (I)wherein R, R, R, Y, Y, Y, A, A, A, and Ahave any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
AbstractList The present invention provides for compounds of formula (I)wherein R, R, R, Y, Y, Y, A, A, A, and Ahave any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS. Also provided are pharmaceutical compositions comprising one or more compounds of formula (I).
Author WANG, Le
DAI, Yujia
MARJANOVIC, Jasmina
SHEPPARD, George S
HASVOLD, Lisa A
MANTEI, Robert A
MCDANIEL, Keith F
PRATT, John
BOGDAN, Andrew
HOLMS, James H
FIDANZE, Steven D
LIU, Dachun
DIETRICH, Justin D
Author_xml – fullname: DAI, Yujia
– fullname: WANG, Le
– fullname: SHEPPARD, George S
– fullname: MANTEI, Robert A
– fullname: PRATT, John
– fullname: HOLMS, James H
– fullname: DIETRICH, Justin D
– fullname: LIU, Dachun
– fullname: MARJANOVIC, Jasmina
– fullname: HASVOLD, Lisa A
– fullname: BOGDAN, Andrew
– fullname: FIDANZE, Steven D
– fullname: MCDANIEL, Keith F
BookMark eNrjYmDJy89L5WRQCnENCXJ0jnT28XRWcAry9_V38fd19PRT8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAcamxpaWZkaOhsZEKAEA7sckIg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE BROMODOMAINE TÉTRACYCLIQUES
TETRACYCLISCHE BROMDOMÄNENHEMMER
ExternalDocumentID EP3539962A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP3539962A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:05:47 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP3539962A13
Notes Application Number: EP20190156935
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190918&DB=EPODOC&CC=EP&NR=3539962A1
ParticipantIDs epo_espacenet_EP3539962A1
PublicationCentury 2000
PublicationDate 20190918
PublicationDateYYYYMMDD 2019-09-18
PublicationDate_xml – month: 09
  year: 2019
  text: 20190918
  day: 18
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies AbbVie Inc
RelatedCompanies_xml – name: AbbVie Inc
Score 3.2329466
Snippet The present invention provides for compounds of formula (I)wherein R, R, R, Y, Y, Y, A, A, A, and Ahave any of the values defined in the specification, and...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title TETRACYCLIC BROMODOMAIN INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190918&DB=EPODOC&locale=&CC=EP&NR=3539962A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-L8ooj0rbitbdY8FGnTllbsB7XKfBptSWEv23AV_30voZu-6NuRwF1y8MvlkvsAuDemTa2XpqXpk6mpGXRMEXOUazqxRKOHihMZPB4nJHw1nmbmrAeLbS6MrBP6JYsjIqJqxHsrz-v1zyOWJ2MrNw_VAodWj0Fhe2rnHaN1owhnz7X9LPVSpjKGlJrkti4qsJKJg47SnrhFizL7_psrklLWvy1KcAz7GTJbtifQ48sBHLJt47UBHMTdfzeSHfQ2p3BX-EXusHf2HDHFzdMYJcdOlChREkZuVKT5yxkogV-wUENh893G5n62W5Z-Dn309_kFKKRBH2BERxUljVEjRLjJOSkJrWqC-CqHMPyTzeU_c1dwJDQkgh3G1jX0249PfoMWta1upS6-Ad2Dddc
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKc6bTsX5WUR2K25rmzaHImva0Wo_Ro0yT6UtGeyyDVfx3_c1dNOL3kIC7yUPfnn8kvcBcK-b81LLDUvVRqah6nRIEXNUqBqx6kYPhSAyeDyKif-qP82MWQsW21wYWSf0SxZHRESViPdK3tfrn0csV8ZWbh6KBU6tHifcdvsNO0bvRhHOrmN708RNWJ8xHPXj1NbqCqxkNEaitGciI5RM6c2pk1LWvz3K5Aj2pyhsWR1DSyy70GHbxmtdOIia_24cNtDbnMAd93g6Zu8sDJjipEmEmqNxECtB7AdOwJP05RSUiceZr6KybHewzJvutqWdQRv5vjgHhcyRAwzooKBkrpcIEWEIQXJCi5IgvvIe9P4Uc_HP2i10fB6FWRjEz5dwWFurDnwYWlfQrj4-xTV616q4kXb5BoQleME
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=TETRACYCLIC+BROMODOMAIN+INHIBITORS&rft.inventor=DAI%2C+Yujia&rft.inventor=WANG%2C+Le&rft.inventor=SHEPPARD%2C+George+S&rft.inventor=MANTEI%2C+Robert+A&rft.inventor=PRATT%2C+John&rft.inventor=HOLMS%2C+James+H&rft.inventor=DIETRICH%2C+Justin+D&rft.inventor=LIU%2C+Dachun&rft.inventor=MARJANOVIC%2C+Jasmina&rft.inventor=HASVOLD%2C+Lisa+A&rft.inventor=BOGDAN%2C+Andrew&rft.inventor=FIDANZE%2C+Steven+D&rft.inventor=MCDANIEL%2C+Keith+F&rft.date=2019-09-18&rft.externalDBID=A1&rft.externalDocID=EP3539962A1